Searchable abstracts of presentations at key conferences in endocrinology

ea0063p34 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Aldosterone measurement in the Diagnosis of primary aldosteronism – comparison between two automated immunoassays and two liquid chromatography tandem mass-spectrometry methods

Fagotto Valentina , Uhl Olaf , Heinrich Daniel , Nirschl Nina , Sturm Lisa , Kratzsch Jurgen , Bae Yoon Ju , Fries Charlotte , Fenske Wiebke , Reincke Martin , Bidlingmaier Martin

Poor agreement between different analytical methods measuring aldosterone concentrations impedes applicability of uniform cut-offs in the diagnostic work-up of primary aldosteronism (PA). We compared 4 analytical methods (2 immunoassays and 2 LC-MS/MS) in plasma samples before and after saline infusion test (SIT). 80 hypertensive patients underwent the standardized diagnostic work-up within the German Conn’s registry. Patients (PA n=39/non-PA n=41) were ...

ea0041ep5 | Adrenal cortex (to include Cushing's) | ECE2016

Paradoxical worsening of lipid metabolism after successful treatment of primary aldosteronism

Adolf Christian , Asbach Evelyn , Dietz Anna , Hahner Stefanie , Quinkler Marcus , Rump Lars Christian , Bidlingmaier Martin , Treitl Marcus , Hallfeldt Klaus , Beuschlein Felix , Reincke Martin

Primary aldosteronism (PA) describes the most frequent cause of secondary arterial hypertension. Aldosterone itself represents a BP-independent cardiovascular risk factor associated with increased rates of morbidity and mortality. Recently a worsening of lipid metabolism after treatment has been described.Objective: Our aim was to analyse changes in lipid parameters according to treatment outcome in PA patients. Data of 215 consecutive PA patients with u...

ea0035oc2.4 | Adrenal clinical | ECE2014

Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals

Weismann Dirk , Raida Anna , Deutschbein Timo , Prejbisz Aleksander , Januszewicz Andrzej , Willenberg Holger S. , Peitzsch Mirko , Darr Roland , Klemm Reiner , Manz Georg , Bidlingmaier Martin , Eisenhofer Graeme , Fassnacht Martin

Aim: To determine diagnostic performance of normetanephrine (NMN) and metanephrine (MN) measured by an enzyme immunoassay (EIA) compared with liquid chromatographic–tandem mass spectrometry (LC-MS/MS).Methods: Subjects included 341 patients (174 males) with a mean age of 52 year (range 13–86) tested for PHEO, which was confirmed in 54 patients. Samples where collected from fasting patients after 30 min of supine rest and analyzed for NMN, MN an...

ea0035p83 | Bone and Osteoporosis | ECE2014

Low-carbohydrate/high-fat diets do not have negative effects on bone density in female rats in contrast to male rats

Zengin Ayse , Kropp Benedikt , Chevalier Yan , Horngacher Amon , Sustarsic Riia , Sustarsic Elahu , Benedix Sarina , Herbach Nadja , Milz Stefan , Bielohuby Maximilian , Bidlingmaier Martin

Ketogenic low-carbohydrate/high fat diets (LC-HFD) induce weight loss in both animals and humans. However, a number of unwanted side effects with these diets have been reported. We have previously shown in male rats that LC-HFDs negatively affect bone growth and bone mineral density, possibly due to macronutrient-induced impairments of the GH/IGF-system. Given the importance of dietary macronutrients in the regulation of bone density in male rats, in this study we investigated...

ea0070aep1001 | Hot topics (including COVID-19) | ECE2020

Obstructive sleep apnea in primary aldosteronism is associated with cortisol cosecretion

Heinrich Daniel , Adolf Christian , Handgriff Laura , Schneider Holger , Nirschl Nina , Obster Elisabeth , Sturm Lisa , Wang Xiao , Bidlingmaier Martin , Wildgruber Moritz , Ladurner Roland , Beuschlein Felix , Reincke Martin

Background: Primary aldosteronism (PA) is a secondary form of arterial hypertension that – in case of unilateral disease – can be cured by surgery. Multiple studies have shown that PA patients are at higher risk to suffer from cardiovascular events and to develop metabolic diseases. Two thirds of patients with PA suffer from obstructive sleep apnea (OSA). A bi-directional, pathophysiological interplay between OSA and PA has been proposed, with focus on overnight ro...

ea0029p74 | Adrenal cortex | ICEECE2012

Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study

Kunzel H. , Apostolopoulou K. , Pallauf A. , Hanslik G. , Volker B. , Evelyn F. , Bidlingmaier M. , Stephan E. , Quinckler M. , Beuschlein F. , Reincke M.

Context: Recent studies showed a high prevalence of anxiety and depressive symptoms in patients with primary hyperaldosteronism (PA). A cross-sectional analysis suggested only minor improvement following adrenalectomy (ADX) and mineralocorticoidreceptor antagonist (MRA) therapy.Objective: Our aim was to determine the course of anxiety and depression in untreated patients.Design: We investigated 15 patients with PA at time of diagno...

ea0019p337 | Steroids | SFEBES2009

The role of serum and urinary steroids in the monitoring of adults with congenital adrenal hyperplasia

Reisch N , Krone N , Hughes B A , Vassiliadi D A , Flade L , Bidlingmaier M , Shackleton C H L , Stewart P M , Arlt W

Glucocorticoid treatment in congenital adrenal hyperplasia (CAH) is a continuous challenge, with even the experienced clinician struggling to strike the right balance between glucocorticoid over- and undertreatment. There is no consensus on monitoring of glucocorticoid therapy in adults with CAH. Some recommend a serum 17-hydroxyprogesterone (17OHP) target range of 12–36 nmol/l prior to glucocorticoid morning dose. Here we investigated the value of serum and urinary stero...

ea0016p37 | Adrenal | ECE2008

The German Conn's registry: comorbidities in over 700 patients with primary hyperaldosteronism

Born-Frontsberg Eric , Schirpenbach Caroline , Hahner Stefanie , Beuschlein Felix , Bidlingmaier Martin , Diederich Sven , Lorenz R , Rump Lars , Seufert Jochen , Endres Stefan , Quinkler Marcus , Reincke Martin

Objective: Hypokalemic Conn’s syndrome is a rare disease with a prevalence of 0.5% in unselected hypertensive populations. However, recent studies indicate a higher prevalence of a milder variant of Conn’s syndrome, reaching 10% in some studies. Long term outcome and health care costs of hypo- and normokalemic variants are largely unknown. The National Conn’s Registry is an initiative to create a national database of sufficient epidemiological strength to invest...

ea0016p40 | Adrenal | ECE2008

Comparison of strategies for biochemical diagnosis of primary aldosteronism in German academic centres

Reuschl S , Schirpenbach C , Hahner S , Beuschlein F , Diederich S , Lorenz R , Rump LC , Seufert J , Endres S , Quinckler M , Reincke M , Bidlingmaier M

Recent studies indicating that normokaliemic primary aldosteronism (PA) is a more frequent cause of hypertension than previously expected led to an increased interest in biochemical screening strategies. We investigated biochemical diagnostic strategies used in different academic centres for patients documented in the German National Conn’s Registry. Data from 7 centres in 5 cities have been entered into a database by trained personnel. For analysis, results from 522 pati...

ea0016p45 | Adrenal | ECE2008

Renal function in patients with primary aldosteronism: comparison with essential hypertension

Reincke Martin , Schirpenbach Caroline , Hahner Stephanie , Beuschlein Felix , Bidlingmaier Martin , Diederich Sven , Lorenz Reinhard , Rump Lars Christian , Seufert Jochen , Meisinger Christa , Holle Rolf , Quinkler Marcus

Objective: Primary aldosteronism (PA) is associated with vascular end organ damage. We evaluated the newly established German Conn’s Register for evidence of renal impairment and compared the data with renal function from hypertensive subjects from an epidemiologic cohort.Methods: The registry was founded in 2006 and has at present 7 participating centres in 5 locations. Data are entered in a central electronic database. Up to July 2007 555 patients...